Tags

Type your tag names separated by a space and hit enter

Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule.
Fed Regist. 2007 Mar 06; 72(43):9849-52.FR

Abstract

The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8 percent coal tar solution and 1.5 percent menthol in a shampoo drug product to control dandruff. FDA did not receive any comments or data in response to its previously proposed rule to include this combination. This final rule is part of FDA's ongoing review of OTC drug products.

Links

FREE Publisher Full Text

Authors

Food and Drug Administration, HHS
No affiliation info available

MeSH

AntipruriticsCoal TarConsumer Product SafetyDermatitis, SeborrheicDrug Therapy, CombinationHair PreparationsHumansMentholNonprescription DrugsPruritusPsoriasisUnited StatesUnited States Food and Drug Administration

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17447341

Citation

Food and Drug Administration, HHS. "Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products Containing Coal Tar and Menthol for Over-the-counter Human Use; Amendment to the Monograph. Final Rule." Federal Register, vol. 72, no. 43, 2007, pp. 9849-52.
Food and Drug Administration, HHS. Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule. Fed Regist. 2007;72(43):9849-52.
Food and Drug Administration, HHS. (2007). Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule. Federal Register, 72(43), 9849-52.
Food and Drug Administration, HHS. Dandruff, Seborrheic Dermatitis, and Psoriasis Drug Products Containing Coal Tar and Menthol for Over-the-counter Human Use; Amendment to the Monograph. Final Rule. Fed Regist. 2007 Mar 6;72(43):9849-52. PubMed PMID: 17447341.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule. A1 - ,, PY - 2007/4/24/pubmed PY - 2007/5/2/medline PY - 2007/4/24/entrez SP - 9849 EP - 52 JF - Federal register JO - Fed Regist VL - 72 IS - 43 N2 - The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) dandruff, seborrheic dermatitis, and psoriasis drug products to include the combination of 1.8 percent coal tar solution and 1.5 percent menthol in a shampoo drug product to control dandruff. FDA did not receive any comments or data in response to its previously proposed rule to include this combination. This final rule is part of FDA's ongoing review of OTC drug products. SN - 0097-6326 UR - https://www.unboundmedicine.com/medline/citation/17447341/Dandruff_seborrheic_dermatitis_and_psoriasis_drug_products_containing_coal_tar_and_menthol_for_over_the_counter_human_use L2 - http://edocket.access.gpo.gov/2007/pdf/E7-3808.pdf DB - PRIME DP - Unbound Medicine ER -